Literature DB >> 1086785

Lymphocyte proliferation in vitro induced by soluble protein antigens. II. Cellular requirements.

B Hertel-Wulff, B Rubin.   

Abstract

Immune guinea pig lymph node cells were fractionated on Ig anti-Ig or HSA anti-HSA affinity columns or on plastic surface in medium containing carbonyl iron. These techniques selectively removed B lymphocytes, K lymphocytes or adherent cells. The residual cells (Fc receptor-negative T lymphocytes) responded to soluble antigen in vitro in the same way or even better compared with nonfractionated cells. In addition, there was no indication that antigen-antibody complexes were superior to antigen in triggering lymph node cells or purified lymph code T lymphocytes into DNA synthesis. The results obtained suggested that memory T lymphocytes can be stimulated by antigen autonomously.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1086785     DOI: 10.1002/eji.1830060608

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  4 in total

1.  Human leucocyte responses in vitro. I. Transformation of purified T lymphocytes with and without addition of partially purified monocytes.

Authors:  G S Hansen; B Rubin; S F Sorensen
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

2.  Corticosteroids decrease the expression of beta 2-microglobulin and histocompatibility antigens on human peripheral blood lymphocytes in vitro.

Authors:  M Hokland; B Larsen; I Heron; T Plesner
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

3.  Cyclosporin A: in vivo and in vitro suppression of rat T-lymphocyte function.

Authors:  J J Burckhardt; B Guggenheim
Journal:  Immunology       Date:  1979-04       Impact factor: 7.397

4.  Cell-mediated cytotoxicity against rat fibroblasts induced by Actinomyces viscosus.

Authors:  R Gaegauf-Zollinger; J J Burckhardt; R Gmür; B Guggenheim
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.